Benchmark Holdings Regulatory News (BMK)

Benchmark Holdings plc 

("Benchmark" or the "Company")

Update on Joint Venture and Placing

Benchmark (LSE:BMK), the aquaculture health, advanced nutrition, and genetics business, is today providing an update on its agreement to fund a Chilean breeding and genetics joint venture with Empresas AquaChile S.A. (the "JV") and the related placing to raise £19.0 million (before expenses) (the "Placing").

Further to the announcement of the Joint Venture and Placing made on 8 June 2018, Benchmark is pleased to announce that it has successfully received Bank Approval and the Placing Shares (34,545,455 ordinary shares of 0.1p each in the Company) are therefore expected to be admitted to trading on AIM at or around 8.00 a.m. (London time) on 25 June 2018.

The Company's total issued share capital following completion of the Placing will consist of 557,075,584 ordinary shares of 0.1 pence each with one voting right per share (assuming no options or warrants are exercised in the period between this announcement and Admission). The above figure of 557,075,584 may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company following Admission.

Capitalised terms used but not defined in this announcement have the same meanings as set out in the announcement of the Company released at 7.00am (London time), 8 June 2018.